RichterKP, LevyS: Big marijuana: Lessons from big tobacco. N Engl J Med, 2014; 371:399–401.
3.
LembergerL, RubinA, WolenR, et al.: Pharmacokinetcs, metabolism, and drug-abuse potential of nabilone. Cancer Treat Rev, 1982; 9:B17–B23.
4.
KoppelBS, BrustJC, FifeT, et al.: Systematic review: Efficacy and safety of medical marijuana in selected neurological disorder: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology, 2014; 82:1556–1563.
5.
GatesPJ, AlbertellaL, CopelandJ: The effects of cannabinoid administration on sleep: A systematic review of human studies. Sleep Med Rev, 2014. E-pub ahead of print.
6.
CichewiczDL, McCarthyEA: Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration. J Pharmacol Exp Ther, 2003; 304:1010–1015.
7.
RussoEB, HohmannAG: Role of cannabinoids in pain management. In: DeerTR, et al. (eds): Comprehensive Treatment of Chronic Pain by Medical, Interventional, and Integrative Approaches. Chicago, IL: American Academy of Pain Medicine Press, 2013.
8.
LynchME, Cesar-RittenbergP, HohmannAF: A double-blind, placebo-controlled crossover pilot trial with extension using an oral mucosal cannabinoid extract for treatment of chemotherapy-induced neuropathic pain. J Pain Symptom Management, 2014; 47:166–173.
9.
VolkowND, BalerRD, ComptonWM, WeissSRB: Adverse health effects of marijuana use. N Engl J Med, 2014; 370:2219–2227.
10.
BachhuberMA, SalonerB, CunninghamCO, BarryCL: Medical cannabis laws and opioid analgesic overdose mortality in the United States, 1999–2010. JAMA Intern Med, 2014; 174:1668–1673.
11.
BorgeltLM, FransonKL, NussbaumAM, et al.: The pharmacologic and clinical effects of medical cannabis. Pharmacotherapy, 2013:33; 195–209.
12.
CarterGT, FlanaganAM, EarleywineM, et al.: Cannabis in palliative medicine: Improving care and reducing opioid-related morbidity. Am J Hosp Palliat Care, 2011; 28:297–303.
13.
AnnasGJ: Medical marijuana, physicians, and state law. N Engl J Med, 2014; 371:983–985.
